ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
4709	Centers for Disease Control and Prevention	Html	en	Questions & Answers - About the Central Vaccine Recovery Program	null	Vaccine Recovery Program 0.865722 H1N1 vaccine 0.695642 federal government 0.208422 unused influenza vaccine 0.51498 H1N1 Sanofi Pasteur 0.284285 Pasteur multidose vials 0.456597 Sanofi Pasteur vaccine 0.516842 vaccine pick 0.349304	regulatory requirements 0.215185 state immunization program 0.232867 H1N1 influenza vaccine 0.545513 vaccine manufacturers 0.38377 Central Vaccine Recovery 0.903278 additional mailing labels 0.204747 vaccine monovalent vaccine 0.735547 HHS Supply Service 0.20992	CLICK HERE
5353	Centers for Disease Control and Prevention	Html	en	Lyme Disease Home Page	Information on Lyme disease. Provided by the U.S. Centers for Disease Control and Prevention.	Steps 0.320635 Health Grand Rounds 0.664331 infection 0.324323 joints 0.326069 characteristic skin rash 0.571271 Innovations 0.320909 fever 0.325819 Typical symptoms 0.429334 infected blacklegged ticks 0.639086 fatigue 0.327395 Feeling 0.325065 lyme disease 0.935028 pesticides 0.324784 bite 0.329099 CDC Public Health 0.661139 tickborne diseases 0.554446	possibility 0.324723 Laboratory testing 0.418285 cases 0.320527 validated methods 0.425561 physical findings 0.42189 infected ticks 0.488065 heart 0.322358 bacterium Borrelia burgdorferi 0.587719 erythema migrans 0.459113 Public Health Grand 0.646971 insect repellent 0.423136 exposure 0.322616 Video 0.356346 headache 0.328776 antibiotics 0.326798 humans 0.324586	CLICK HERE
5648	Centers for Disease Control and Prevention	Html	en	alpha-Methyl styrene - NIOSH Pocket Guide to Chemical Hazards	null	MPEG 0.378858 search 0.263099 PDF 0.261307 PPT 0.446092	DOC 0.368812 information 0.262482 different file formats 0.938484 page 0.276773	CLICK HERE
6039	Centers for Disease Control and Prevention	Html	en	Crufomate - NIOSH Pocket Guide to Chemical Hazards	null	MPEG 0.378858 search 0.263099 PDF 0.261307 PPT 0.446092	DOC 0.368812 information 0.262482 different file formats 0.938484 page 0.276773	CLICK HERE
6728	Centers for Disease Control and Prevention	Html	en	Assessment of Declines in Reported Tuberculosis Cases --- Georgia and Pennsylvania, 2009	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	private laboratories 0.366705 TB surveillance practices 0.356884 TB case reports 0.348419 TB disease 0.344767 TB case definition 0.353678 long-term TB trends 0.33835 report TB cases 0.323107 TB diagnosis-related changes 0.318752 culture-negative TB pleurisy 0.316127 TB transmission 0.280279 TB case rates 0.357725 uncounted TB case 0.33149 culture-negative TB 0.32294 unidentified TB cases 0.37707 TB surveillance 0.409194 Pennsylvania TB cases 0.375498 public health 0.652223 preimmigration TB detection 0.300504 new TB disease 0.297743 TB Prevention 0.314557 suspected TB report 0.335732 tb elimination 0.323289	TB surveillance systems 0.304695 state TB registries 0.347448 TB diagnosis trends 0.322052 TB surveillance data 0.313575 incident TB disease 0.303368 new TB cases 0.325234 M. tuberculosis complex 0.478296 TB reports 0.431232 TB rates 0.322762 TB 0.928052 Pennsylvania 0.400552 countable TB 0.331359 extrapulmonary TB 0.319183 overseas TB screening 0.358255 national TB surveillance 0.384447 positive TB results 0.36376 laboratory-confirmed TB 0.324936 public health laboratories 0.335398 Georgia 0.356682 potential TB diagnoses 0.32695 TB symptoms 0.283619 TB case 0.473964	CLICK HERE
7727	Centers for Disease Control and Prevention	Html	en	Science Clips - Monday, November 26, 2012	null	endorsement 0.376978 current awareness 0.392202 findings 0.334227 asterisk 0.323743 Communicable Diseases 0.41673 full-text link 0.397856 Disease Control 0.392746 CDC Science Clips 0.79136 clinicians 0.31802 factual accuracy 0.393704 area 0.317265 issue 0.338968 Science Clips Production 0.502409 Chief Science Officer 0.495586 conclusions 0.317794 scientific articles 0.419233 DHHS 0.423404 regular format 0.402923 DISCLAIMER 0.32116 proofs 0.318363 general review articles 0.499563 public domain 0.400377 CDC licensed materials 0.643806 Stephen B. Thacker 0.667981 current Vital Signs 0.500557	(www.cdc.gov/vitalsigns). 0.410148 items 0.344508 SFX window 0.409655 authoritative sources 0.407246 public health professionals 0.487995 scientific information 0.401407 omission 0.323254 views 0.331355 weekly digest 0.411275 Science Clips 0.935758 informational purposes 0.387392 public health literature 0.469583 SFX server 0.41036 permission 0.318169 B. Thacker CDC 0.826901 background information 0.401991 original authors 0.392825 opinion 0.32769 non-CDC Websites 0.392789 original sources 0.399744 Vol. 0.320014 service 0.31702 CDC Vital Signs 0.69327 news sources 0.394072	CLICK HERE
10402	Centers for Disease Control and Prevention	Html	en	Preventing Chronic Disease | Designing Audience-Centered Interactive Voice Response Messages to Promote Cancer Screenings Among Low-Income Latinas - CDC	Cancer screening rates among Latinas are suboptimal. The objective of this study was to explore how Latinas perceive cancer screening and the use and design of interactive voice response (IVR) messages to prompt scheduling of 1 or more needed screenings.	study participants 0.378196 Cancer screening rates 0.482237 thematic content analysis 0.38125 emergent themes 0.390395 preventive screening 0.429651 insufficient insurance coverage 0.384367 American Cancer Society 0.395141 overdue screenings 0.373404 CHC staff 0.404234 screening outcome 0.43035 CRC screening 0.44281 patients 0.387802 cervical cancer screening 0.46735 screening needs 0.408549 lower screening rates 0.453624 CHC patients 0.386917 different screenings 0.371773 CHC’s telephone 0.383716 culturally appropriate messages 0.367544 reminder message 0.368782 screening status 0.431589 women 0.46338 IVR messages 0.902397 cancer screening 0.794038	interactive voice response 0.377996 single screening 0.497998 screening appointment 0.42105 screening process 0.412485 multiple screenings 0.611318 multiple IVR messages 0.409274 Dana-Farber Cancer Institute 0.379362 cancer screenings 0.50238 multiple IVR reminder 0.388635 focus groups 0.553346 underserved Latina patients 0.382704 Focus group participants 0.377101 health care 0.370029 participants 0.507116 overdue cancer screenings 0.400665 breast cancer screening 0.462396 health 0.387557 specific screening test 0.441757 cancer screening tests 0.441321 native speaker 0.366712 screening procedures 0.406277 et al 0.369311 IVR programming 0.368895 different recommended screening 0.450236	CLICK HERE
10425	Centers for Disease Control and Prevention	Html	en	Public Health Action Plan-2004 Update'About Us'DHDSP'CDC	null	priority action steps 0.993694 Prevent Heart Disease 0.848158 National Forum 0.757862 efforts 0.200128 Public Health Action 0.816938	Action Plan 0.644279 Stroke Prevention 0.630639 visit /dhdsp/action_plan/index.htm 0.530191 action involved— 0.548433 concrete tasks 0.586767	CLICK HERE
12397	Centers for Disease Control and Prevention	Image	null	Child Passenger Safety (1175W x 347H)	null			CLICK HERE
12481	Centers for Disease Control and Prevention	Video	en	October 2013 ACIP Meeting -- Herpes Zoster Vaccine (HZV)	Introduction by Dr. J Duchin. Long term persistence study and vaccine supply by Dr. J Parrino and Dr. E Bresnitz. Burden of HZ disease and effectiveness of HZV in older adults by Dr. C Hales. Decision and cost-effectiveness of HZV in adults ?50 years of age by Dr. I Ortega-Sanchez. WG considerations for use of HZV in adults 50-59 years of age by Dr. C Hales. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod.php?id=f5cb2c81eb0e5dc8b7915c3f8fbd02b720140110105538895	HZV 0.314713 Herpes Zoster Vaccine 0.958762	ACIP Meeting 0.758221	CLICK HERE